Other OTC - Delayed Quote • USD
Amarantus BioScience Holdings, Inc. (AMBS)
At close: April 23 at 1:20 PM EDT
Breakdown
TTM
Operating Expense
20,935.0000
Operating Income
-20,935.0000
Net Non Operating Interest Income Expense
-3,464.0000
Other Income Expense
4,189.0000
Pretax Income
-20,210.0000
Net Income Common Stockholders
-42,282.0000
Diluted NI Available to Com Stockholders
-42,282.0000
Basic EPS
-3.52
Diluted EPS
-3.52
Basic Average Shares
15,499.9240
Diluted Average Shares
15,499.9240
Total Operating Income as Reported
-20,935.0000
Total Expenses
20,935.0000
Net Income from Continuing & Discontinued Operation
-20,210.0000
Normalized Income
-24,399.0000
Interest Expense
3,464.0000
Net Interest Income
-3,464.0000
EBIT
-16,746.0000
EBITDA
-16,601.0000
Reconciled Depreciation
145.0000
Net Income from Continuing Operation Net Minority Interest
-20,210.0000
Total Unusual Items Excluding Goodwill
4,189.0000
Total Unusual Items
4,189.0000
Normalized EBITDA
-20,790.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NB11.F Vaxart, Inc.
0.6335
-3.06%
BIOAF Bioasis Technologies Inc.
0.0040
0.00%
296.SG CytoDyn Inc
0.1350
-1.46%
FRTX Fresh Tracks Therapeutics, Inc.
0.9206
-1.01%
CWBR CohBar, Inc.
0.8000
0.00%
MACK Merrimack Pharmaceuticals, Inc.
14.73
+0.14%
NYMXF Nymox Pharmaceutical Corporation
0.3000
-6.25%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.4750
-12.04%
COEP Coeptis Therapeutics Holdings, Inc.
0.3220
-1.53%
ACOGF Alpha Cognition Inc.
0.4950
+0.45%